Clinical trials
Active, not recruiting Phase 1 Alzheimer Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baylor College of Medicine | 1 |
| Boston University | 1 |
| Hoffmann-La Roche | 1 |
| Institute for Molecular Medicine | 1 |
| Lexeo Therapeutics | 1 |
| Mark Tuszynski | 1 |
| Mclean Hospital | 1 |
| National University Hospital, Singapore | 1 |
| Novartis Pharmaceuticals | 1 |
| Oligomerix, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 16 |
| Cognitive Dysfunction | 6 |
| Dementia | 3 |
| Tauopathies | 2 |
| Anxiety Disorders | 1 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Memory Disorders | 1 |
| Nervous System Diseases | 1 |
| Neurocognitive Disorders | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.